RH

Ronald Henri Francois De Lagrange Chancel

Director Director DIN 06646569
DIN 06646569 First appointment Sep 2013 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Sep 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Ronald Henri Francois De Lagrange Chancel

Data last updated:

Ronald Henri Francois De Lagrange Chancel was a Director at Maco Pharma India Transfusion Solutions Private Limited (2013–2018). The company operates in Pharma.

DIN 06646569
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Sep 20132013₹11.32 Cr (FY 2023)Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Maco Pharma India Transfusion Solutions Private Limited
Premium access

Shareholding and investment profile for Ronald Henri Francois De Lagrange Chancel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ronald Henri Francois De Lagrange Chancel

Ronald Henri Francois De Lagrange Chancel was first appointed on 26 Sep 2013 as Director at Maco Pharma India Transfusion Solutions Private Limited.

Ronald Henri Francois De Lagrange Chancel held 1 earlier board appointment: Maco Pharma India Transfusion Solutions Private Limited (Director, 26 Sep 2013 to 05 Mar 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available